Future cohort studies that monitor Ab levels of participants at baseline and following consecutive MDA rounds are required to elucidate the kinetics of Ab and Ag behaviour to determine whether monitoring Ab prevalence is an appropriate measure of LF transmission and infection. The gene discussed is RENBP; the disease is infection.